Multinational, Placebo-Controlled, Randomized Trial of the Effects of Alendronate on Bone Density and Fracture Risk in Postmenopausal Women with Low Bone Mass: Results of the FOSIT Study
H. A. P. Pols(Erasmus MC), Dieter Felsenberg(Freie Universität Berlin), David A. Hanley(University of Calgary), J Štěpán(Charles University), Manuel Muñoz‐Torres(Instituto de Investigación Biosanitaria de Granada), Terence J. Wilkin, Qin-sheng Ge(Peking Union Medical College Hospital), A.M. Galich(Hospital Italiano de Buenos Aires), K. Vandormael(MSD (Belgium)), A.J.P. Yates(Merck & Co., Inc., Rahway, NJ, USA (United States)), B Stych(Merck & Co., Inc., Rahway, NJ, USA (United States)), for the Fosamax® International Trial Study Group
Cited by 594
Abstract
Related Papers
No related papers found
Powered by citation graph analysis